Open AccessPerformance of Dexcom G5 and FreeStyle Libre sensors tested simultaneously in people with type 1 or 2 diabetes and advanced chronic kidney disease
Author(s) -
Arndís F. Ólafsdóttir,
Mervi Andelin,
Aso Saeed,
Sheyda Sofizadeh,
Hussein Hamoodi,
PerAnders Jansson,
Marcus Lind
Publication year - 2022
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v10.i22.7794
Subject(s) - medicine , diabetes mellitus , kidney disease , type 1 diabetes , type 2 diabetes , population , hemodialysis , continuous glucose monitoring , blood glucose self monitoring , peritoneal dialysis , glucose meter , endocrinology , environmental health
Advanced chronic kidney disease (CKD) is a common complication for people with type 1 and 2 diabetes and can often lead to glucose instability. Continuous glucose monitoring (CGM) helps users monitor and stabilize their glucose levels. To date, CGM and intermittent scanning CGM are only approved for people with diabetes but not for those with advanced CKD.